Abstract:Background The first community transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant of concern (VOC) in Guangzhou, China occurred between May and June 2021. Herein, we describe the epidemiological characteristics of this outbreak and evaluate the implemented containment measures against this outbreak. Methodology/Principal findings Guangzhou Center for Disease Control and Prevention provided the data on SARS-CoV-2 infections reported between 21 May and 24 June 2021. We estimated the incubation period distribution by fitting a gamma distribution to the data, while the serial interval distribution was estimated by fitting a normal distribution. The instantaneous effective reproductive number (R-t) was estimated to reflect the transmissibility of SARS-CoV-2. Clinical severity was compared for cases with different vaccination statuses using an ordinal regression model after controlling for age. Of the reported local cases, 7/153 (4.6%) were asymptomatic. The median incubation period was 6.02 (95% confidence interval [CI]: 5.42-6.71) days and the means of serial intervals decreased from 5.19 (95% CI: 4.29-6.11) to 3.78 (95% CI: 2.74-4.81) days. The incubation period increased with age (P< 0.001). A hierarchical prevention and control strategy against COVID-19 was implemented in Guangzhou, with Rt decreasing from 6.83 (95% credible interval [CrI]: 3.98-10.44) for the 7-day time window ending on 27 May 2021 to below 1 for the time window ending on 8 June and thereafter. Individuals with partial or full vaccination schedules with BBIBP-CorV or CoronaVac accounted for 15.3% of the COVID-19 cases. Clinical symptoms were milder in partially or fully vaccinated cases than in unvaccinated cases (odds ratio [OR] = 0.26 [95% CI: 0.07-0.94]). Conclusions/Significance The hierarchical prevention and control strategy against COVID-19 in Guangzhou was timely and effective. Authorised inactivated vaccines are likely to contribute to reducing the probability of developing severe disease. Our findings have important implications for the containment of COVID-19. Author summary On 11 May 2021, the WHO reclassified the B.1.617.2 variant as a "variant of concern" (VOC) from being a "variant of interest", considering its global public health significance. On 21 May 2021, the first local case infected with the Delta variant (i.e. lineage B.1.617.2) in Guangzhou, China, was reported. In response to the resurgence of COVID-19, the local government implemented a series of containment measures. This provides a valuable opportunity to understand the characteristics of the Delta variant and to evaluate the performance of inactivated COVID-19 vaccines (BBIBP-CorV and CoronaVac) and other interventions. We estimated that the median incubation period was 6.02 days and the means of serial intervals decreased from 5.19 to 3.78 days. The incubation period increased with age. The vaccination coverage in the COVID-19 cases was 15.3%. Clinical symptoms were milder in cases with partial or full vaccination than in those who were unvaccinated (odds ratio [OR] = 0.26). We found that the effective reproductive number decreased from 6.83 for the 7-day time window ending on 27 May 2021 to below 1 for the time window ending on 8 June and thereafter. Our findings have important implications for the containment of COVID-19.

First Imported Case of SARS-CoV-2 Omicron Subvariant BA.4 — Guangdong Province, China, May 4, 2022

Complete Genome Sequences of the SARS-CoV: the BJ Group (isolates BJ01-BJ04).

Tracking the First SARS-CoV-2 Omicron BA.5.1.3 Outbreak in China.

An Outbreak of the SARS-CoV-2 Omicron Variant BA.1 — Zhuhai City, Guangdong Province, China, January 13, 2022

Emergence of a SARS-CoV-2 Omicron Subvariant BA.2.2 with a 454-Nucleotide Genomic Deletion — Sichuan Province, China, May 10, 2022

Eleven COVID-19 Outbreaks with Local Transmissions Caused by the Imported SARS-CoV-2 Delta VOC — China, July–August, 2021

Prevalence and diversity of imported severe acute respiratory syndrome coronavirus 2 variants in China, 2021–2022

Whole-Genome Sequences Analysis Displays Relationship of SARS-CoV-2 Delta Variant Between Four Local Cases and Passengers of a Flight from South Africa — Shenzhen City, Guangdong Province, China, June 2021

Research of Epidemiologic Feature and Control of SARS-CoV-2 Omicron Subvariants BA.4 and BA.5

Epidemiological and clinical features of children with the Omicron BA.5.2 subvariant in Guangzhou

Prevalence of SARS-CoV-2 Omicron Variants and Epidemiological Characteristics of Subvariant XBB Infections in Pudong New Area,Shanghai During January-June 2023

Clinical and Virological Characteristics of SARS-CoV-2 Omicron BA.2.2 Variant Outbreaks During April to May, 2022, Shanghai, China

The Omicron BA.2.2.1 subvariant drove the wave of SARS-CoV-2 outbreak in Shanghai during spring 2022

Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China

Sequencing on an imported case in China of COVID‐19 Delta variant emerging from India in a cargo ship in Zhoushan, China

Transmission and Containment of the SARS-CoV-2 Delta Variant of Concern in Guangzhou, China: A Population-Based Study

Rapid spread of SARS-CoV-2 Omicron subvariant BA.2 in a single-source community outbreak

Genomic evolution of BA.5.2 and BF.7.14 derived lineages causing SARS-CoV-2 outbreak at the end of 2022 in China

Virological characteristics of SARS-CoV-2 Omicron BA.5.2.48

Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis

Genomic Surveillance for SARS-CoV-2 — China, September 26, 2022 to January 29, 2023